Peer-reviewed journal articles published within the last six months are listed here, linked from relevant news stories when appropriate. To learn more on how to best read and interpret the findings from clinical research, see
In Brief: Interpreting Research Studies from the Guttmacher Institute.
Contraception
Blithe D. Male Contraception: What Is On the Horizon? Contraception, 2008 October;78(4):23-27. 
Gerscovich EO, Park CW, Dulude MZ, et al. Increased Rotational Mobility of the Testis After Vasectomy: A Sonographic Study. Journal of Ultrasound in Medicine . 2008 Dec;27(12):1667-72
Goyal NK, Kumar A, Das SK, et al. Experience with Plaque Excision and Dermal Grafting in the Surgical Treatment of Peyronie's Disease. Singapore Medical Journal. 2008 Oct;49(10):805-8.
Gray RH, Wawer MJ, Serwadda D, et al. The Role of Male Circumcision in the Prevention of Human Papillomavirus and HIV infection. Journal of Infectious Diseases 2009;199:1-3.
Kopf G S. Approaches to the Identification of New Nonhormonal Targets for Male Contraception. Contraception. 2008 October ;78(4):18-22.
Genuis SJ. Are condoms the answer to rising rates of non-HIV sexually transmitted infection? No. BMJ. 2008 Jan 26; 336(7637):185.
Liu PY et al. Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: An integrated analysis. J Clin End & Metab. 2008 Feb 26.
Martino SC, Elliott MN, Collins RL, Kanouse ED, Berry SH. Virginity pledges among the willing: Delays in first intercourse and consistency of condom use. J Ado Health. 2008 June 5.
Wang C, Nieschlag E, Swerdloff R , et al . Investigation, Treatment and Monitoring of Late-onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA and ASA recommendations. European Journal of Endocrinology. 2008 Nov;159(5):507-14.
Men & Fertility/Infertility
Akbal C, Türker P, Ozyürek M, et al. A New Cause of Male Infertility After Cisplatin Exposure: The Effect of Cisplatin on Y Chromosomes. Urology. 2008 Apr 11.
Antinori M et al. Intracytoplasmic morphologically selected sperm injection: A prospective randomized trial. Reprod Biomed Online. 2008 June; 16(6):835-841.
Belloc S et al. The effect of maternal and paternal age on pregnancy miscarriage rates after IUI. Reprdo Biomed Online. 2008 Jul.
Chavarro JE, Toth TL, Sadio SM, Hauser R. Soy food and isoflavone intake in relation to semen quality parameters among men from an infertility clinic. Hum Reprod. 2008 July 23.
Christiansen S, Scholze M, Axelstad M, Boberg J, Kortenkamp A, Hass U. Combined exposure to anti-androgens causes markedly increased frequencies of hypospadias in the rat. International J Andrology. 2008 Jan 22.
Cohen-Bacrie P, Belloc S, Menezo YJR, Clement P, Hamidi J, Benkhalifa M. Correlation between DNA damage and sperm parameters: A prospective study of 1,633 patients. Fert Stert. 2008 Apr 25.
Cox, B. Erectile Dysfunction and Heart disease 1: Overview. Nursing Times. 2008 104; (46):26–27.
Ferlin A, Zuccarello D, Zuccarello B, et al. Genetic Alterations Associated With Cryptorchidism. JAMA. 2008 Nov 19;300(19):2271-6
Flacke S et al. Embolization of varicocles: Pretreatment sperm motility predicts later pregnancy in partners of infertile men. Radiology. 2008 Aug; 248(2):540-549.
Koskimäki J, Shiri R, Tammela T, Häkkinen J, Hakama M, Auvinen A. Regular intercourse protects against erectile dysfunction: Tampere Aging Male Urologic Study. Am J Med. 2008 July; 121(7):592-596.
Kumanov P, Robeva RN, Tomova A. Adolescent varicocele: Who is at risk? Pediatrics. 2008 Jan 1; 121(1):53-57.
Nargund VH. Health issues of cycling in men. BJU Inter. 2008 June 28.
Patel SR, Sigman M. Comparison of outcomes of vasovasostomy performed in the convoluted and straight vas deferens. J Urology. 2008 Jan; 179(1):256-259.
Phillips KP, Tanphaichitr N. Human exposure to endocrine disrupters and semen quality. J Toxicol Environ Health B Crit Rev; 2008 Mar; 11(3-4):188-220.
Steinsvik EA, Fosså SD, Lilleby W, Eilertsen K. Fertility issues in patients with prostate cacner. BJU Int. 2008 May 16.
Tal R, Voelzke BB, Land S, et al. Vasculogenic Erectile Dysfunction in Teenagers: A 5-Year Multi-Institutional Experience. BJU International. 2008 Oct 24.
Welsh M et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest. 2008 March 13.
Yang F et al. Meiotic failure in male mice lacking an X-linked factor. Genes Dev. 2008 Mar 1; 22(5):682-691.
Young SS, Eskenazi B, Marchetti FM, Block G, Wyrobek AJ. The association of folate, zinc and antioxidant intake with sperm aneuploidy in healthy non-smoking men. Hum Reprod. 2008 Mar 19.
Male Cancers
Abdulghani J et al. Stat3 promotes metastatic progression of prostate cancer. Am J Pathol. 2008 June; 172(6):1717-1728.
Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL. Statin use and risk of prostate cancer: Results from a population-based epidemiologic study. Am J Epidemiol. 2008 Aug; 168(3):250-260.
Allen NE et al. Animal foods, protein, calcium and prostate cancer risk: The European prospective investigation into cancer and nutrition. Brit J Cancer. 2008; 98:1574-1581.
Antonopoulos IM et al. Radical retropubic prostatectomy for localized prostate cancer in renal transplant patients. Urology. 2008 May 14.
Attard G et al. Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. BJ Cancer. 2008 July: 99(2):314-320.
Attard G et al. Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone drive. JCO. 2008 July 21.
Bartsch G et al. Tyrol prostate cancer demonstration project: Early detection, treatment, outcome, incidence and mortality. BJU International. 2008 Apr; 101(7):809-816.
Beer TM et al. C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: Results from the ASCENT trial. Cancer. 2008 Apr 21.
Beer TM et al. Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel. Cancer. 2008 Jan 15; 112(2):326-330.
Bill-Axelson A et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: The Scandinavian prostate cancer group-4 randomized trial. JNCI. 2008 Aug; 100(16):1144-1154.
Birnie R et al. Gene expression profiling of human prostate cancer cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol. 2008 May 20:9(5):R83.
Briganti A et al. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. Eur Urology. 2008 May 21.
Burton JB et al. Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer. Nature Medicine. 2008 July 11.
Chamie K, Devere White RW, Volpp B, Lee D, Ok J, Ellison LM. Agent Orange exposure, Vietnam War veterans and the risk of prostate cancer. Cancer. 2008 July 29.
Colli JL, Amling CL. Prostate Cancer Mortality Rates Compared to Urologist Population Densities and Prostate-Specific Antigen Screening Levels on a State-by-State Basis in the United States of America. Prostate Cancer and Prostatic Diseases . 2008;11(3):247-251.
Collin et al. Prostate-cancer mortality in the USA and UK in 1975-2004: An ecological study. The Lancet Oncology. 2008 Apr 16.
D’Amico AV, Chen M-H, Renshaw AA, Loffredo M, Kantoff PW. Androgen suppression and radiation vs radiation alone for prostate cancer. JAMA. 2008 Jan 23; 299(3):289-295.
Daley D et al. Identification of susceptibility genes for cancer in a genome-wide scan: Results from the colon neoplasia sibling study. Am J Human Genetics. 2008 Mar 3; 82(3):723-736.
Eeles Eeles RA et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nature Genetics. 2008 Feb 10; 40(2):189-197.
Efstathiou JA, Skowronski RY, Coen JJ, Grocela JA, Hirsch AE, Zietman AL. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.Intern J Rad Oncol Bio Phy. 2008 Aug; 71(5):1302-1308.
Farmer MM, Bastani R, Kwan L, Belman M, Ganz PA. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan. Cancer. 2008 Feb 11.
Flaig TW , Glodé LM. Management of the Side Effects of Androgen Deprivation Therapy in Men with Prostate Cancer. Expert Opinion on Pharmacotherapy . 2008 Nov;9(16):2829-41
Freedland SJ et al. Obesity and oncological outcome after radical prostatectomy: Impact of prostate-specific antigen-based prostate cancer screening: Results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Cancer Databases. BJU Intern. 2008 Aug 7.
Frosch DL, Bhatnagar V, Tally S, Hamori CJ, Kaplan RM. A randomized controlled trial comparing alternative approaches for men considering prostate cancer screening. Arch Intern Med. 2008 Feb 25; 168(4):363-369 .
Gilbert SM, Daignault S, Weizer AZ, Wei JT, Hollenbeck BK. The use of tumor markers in testis cancer in the United States: A potential quality issue. Urol Oncol. 2008 Mar-Apr; 26(2):153-157.
Han JH et al. Association between serum prostate-specific antigen level, liver function tests and lipid profile in healthy men. BJU International. 2008 Jun 3.
Harvard Health Publications. State-of-the-heart therapy for prostate cancer. Harvard Heart Letter. 2008 Apr 1.
Hill MM et al. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell. 2008 Jan 11; 132:113-124.
Jørgensen KT, Pedersen BV, Johansen C, Frisch M. Fatherhood status and prostate cancer risk. Cancer. 2008 Jan 7.
Kinsey T, Jemal A, Liff J, Ward E, Thun M. Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst. 2008 July; 100(14):1003-1012.
Kobayashi N et al. Effect of low-fat diet on development of prostate cancer and akt phosphorylation in the hi-myc transgenic mouse model. Cancer Research. 2008 Apr 18; 68(8):3066-3073.
Krishnadasan A, Kennedy N, Zhao Y, Morgenstern H, Ritz B. Nested case-control study of occupational physical activity and prostate cancer among workers using a job exposure matrix. Cancer Causes Control. 2008 Feb; 19(1):107-114.
Langley RE et al. Early hormonal data from a multicentre phase II trail using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer. BJU Intern. 2008 Aug; 102(4):442-445.
Lakshman M et al. Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Research. 2008 Mar 15; 68(6):2024-2032.
Larson BT et al. Blood pressure surges during office-based transurethral microwave therapy for the prostate. Mayo Clin Proc. 2008 Mar; 83(3):309-312.
Lu-Yao GL et al. Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA. 2008 July 9; 300(2):173-181.
Madan RA et al. Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, Nilutamide and combination therapy. Clinical Cancer Research. 2008 July 15; 14(14):4526-4531.
Masters J R, Kane C, Yamamoto H, et al. Prostate Cancer Stem Cell Therapy: Hype or Hope? Prostate Cancer and Prostatic Diseases. 2008;11(4):316-319
McDonnell TJ et al. Biomarker expression patterns that correlate with high grade features in treatment naïve, organ-confined prostate cancer. BMC Medical Genomics. 2008 Jan 31; 1:1.
McKenna DA et al. Prostate cancer: Role of pretreatment MR in predicting outcome after external-beam radiation therapy – initial experience. Radiology. 2008 Apr; 247(1):141-146.
Mohan R. Family physicians could help in predicting life expectancy without prostate cancer. J Clin Oncol. 2008 Feb 1; 26(4):690-691.
Montgomery RB et al. Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth. Cancer Research. 2008 June 1; 68(11):447-4454.
Mossine VV, Chopra P, Mawhinney TP. Interaction of tomato lycopene and ketosamine against rat prostate tumorigenesis. Cancer Research. 2008 June 1; 68(11):4384-4391.
Myles P et al. Diagnostic radiation procedures and risk of prostate cancer. British J Cancer. 2008 Jun 3; 98(11):1852-1856.
Nelson CJ, Lee JS, Gamboa MC, Roth AJ. Cognitive effects of hormone therapy in men with prostate cancer. Cancer. 2008 July 29.
Niu Y et al. Androgen receptor is a tumor suppressor and proliferator in prostate cancer. PNAS. 2008 Aug; 105(34):12182-12187.
Orsini N, Mantzoros CS, Wolk A. Association of physical activity with cancer incidence, mortality, and survival: A population-based study of men. British J Cancer. 2008 May 27; 98(11):1864-1869.
Pinkawa M, Gagel B, Asadpour B, et al. Seed Displacements after Permanent Brachytherapy for Prostate Cancer in Dependence on the Prostate Level Strahlentherapie und Onkologie . 2008 Oct;184(10):520-525.
Press OA et al. Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer. Cancer Research. 2008 Apr 18; 68(8):3037-3042.
Rajinikanth A, Manoharan M, Soloway CT, Civantos FJ, Soloway MS. Trends in Gleason score: Concordance between biopsy and prostatectomy over 15 years. Urology. 2008 Feb 15.
Ream E et al. Supportive care needs of men living with prostate cancer in England: A survey. Brit J Cancer. 2008; 98:1903-1909.
Redman MW, Tangen CM, Goodman PJ, Lucia MS, Coltman Jr CA, Thompson IM. Finasteride does not increase the risk of high-grade prostate cancer: A bias-adjusted modeling approach. Cancer Prevention Research. 2008 May 18.
Richert-Boe KE et al. Racial differences of early-state prostate cancer. Urology. 2008 June; 71(6):1172-1176.
Roddam AW , Allen NE, Appleby P, et al. Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies. Annals of Internal Medicine, 2008 Oct 7;149(7):461-471.
Roehrborn CG. The effects of Dutasteride, Tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2 year results from the CombAT study. J Urol. 2008 Feb; 179(2):616-621.
Sanda MG et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. NEJM. 2008 Mar 20; 358(12):1250-1261.
Sargeant AM et al. OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinomas of the mouse prostate model. Cancer Research. 2008 May 15; 68(10):3999-4009.
Scales DD Jr, Antonelli J, Curtis LH, Schulman KA, Moul JW. Prostate-specific antigen screening among young men in the United States. Cancer. 2008 Aug 11.
Scattoni V et al. Initial extended transrectal prostate biopsy – Are more prostate cancers detected with 18 cores than with 12 cores? J Urology. 2008 Apr; 179(4):1327-1331.
Setlur SR et al. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. JNCI. 2008 June; 100(11):815-825
Shariat SF et al. Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy. J Urol. 2008 Feb 21.
Shariat SF et al. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers. Clinical Cancer Research. 2008 June; 14(12):3785-3791.
Somford DM , Fütterer JJ, Hambrock T, et al. Diffusion and Perfusion MR Imaging of the Prostate. Magnetic Resonance Imaging Clinics of North America . 2008 Nov;16(4):685-95
Spencer BA et al. Variations in quality of care for men with early-stage prostate cancer. J Clin Oncol. 2008 Aug; 26(22):3735-3742.
Strom S, Yamamura Y, Forman MR, Pettaway CA, Barrera SL, DiGiovanni J. Saturated fat intake predicts biochemical failure after prostatectomy. Int J Cancer. 2008 Mar; 122(11):2581-2585.
Suzuki H. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade. J Urology. 2008 Sept; 180(3):921-927.
Thomas G et al. Multiple loci identified in a genome wide association study of prostate cancer. Nature Genetics. 2008 Mar; 40(3):310-315.
Tomlins SA et al. The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell. 2008 June 10; 13(6):519-528.
Torkko KC et al. VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic white and Hispanic white men. Clinical Cancer Research. 2008 May 15; 14(10):3223-3229.
Trock BJ et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA. 2008 June; 299(23):2760-2769.
U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Annuals Intern Med. 2008 Aug; 149(3):185-191.
Wallace TA et al. Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Research. 2008 Feb 1; 68(3):927-936.
Weight CJ, Klein EA, Jones JS. Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population. Cancer. 2008 Apr 7.
Weiss JM et al. Endogenous sex hormones and the risk of prostate cancer: A prospective study. Int J Cancer. 2008 Jan 2.
The Male Role in Reproductive Health
Bentley RA, Wahl J, Price TD, Atkinson TC. Isotopic signatures and hereditary traits: Snapshot of a Neolithic community in Germany. Antiquity. 2008 June; 82(316):290-304.
Berger LM, Carlson MJ, Bzostek SH, Osborne C. Parenting practices of resident fathers: The role of marital and biological ties. J Marriage and Family. 2008 Aug; 70(3):625-639.
Black KL et al. PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model. Brain Research. 2008 July 14.
Bogaert V et al. Heritability of blood concentrations of sex-steroids in relation to body composition in young adult male siblings. Clin Endocrinol. 2008 July; 69(1):129-135.
Brugts MP et al. Low circulating IGF-I bioactivity in elderly men is associated with increased mortality. J Clin Endo & Metab. 2008 Apr 15.
Chen X-K, Wen SW, Krewski D, Fleming N, Yang Q, Walker MC. Paternal age and adverse birth outcomes: Teenager or 40+, who is at risk? Hum Reprod. 2008 Feb 6.
Choi S-K, Yoon S-R, Calabrese P, Arnheim N. A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutations. PNAS. 2008 July 16.
Cinar A et al. Cluster analysis and lower urinary tract symptoms in men: Findings from the Boston Area Community Health Survey. BJU Int. 2008 May; 101(10):1247-1256.
Diep BA et al. Emergency of Multidrug-Resistant, community-associated, Methicillin-Resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med. 2008 Jan 14.
Emmelot-Vonk MH et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men. JAMA. 2008 Jan 2; 299(1):39-52.
Giles DC, Close J. Exposure to ‘lad magazines’ and drive for muscularity in dating and non-dating young men. Personality and Individual Differences. 2008 May; 44(7):1610-1616.
Grear DA, Perkins SE, Hudson PJ. Testosterone drives parasite exposure and transmission potential in wild mice. 2008 Aug; 93 rd ESA annual meeting.
Grossmann M et al. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin End & Metab. 2008 Mar 4.
Hall SA et al. Treatment of symptomatic androgen deficiency: Results from the Boston Area Community Health Survey. Arch Intern Med. 2008; 168(10):1070-1076.
Kind J et al. Genome-wide analysis reveals MOF as a key regulator of dosage compensation and gene expression in Drosophila. Cell. 2008 May 30; 133:813-828.
Klein MI et al. Differential gender response to respiratory infections and to the protective effect of breast milk in preterm infants. Pediatrics. 2008 June 6; 121(6):e1510-1516.
Liu H, Umberson D. The times they are a changin’: Marital status and health differentials from 1972 to 2003. J Health Soc Behav. 2008 Sept; 49(3):239-253.
Lydon JE, Menzies-Toman D, Burton K, Bell C. If-then contingencies and the differential effects of the availability of an attractive alternative on relationship maintenance for men and women. J Personality and Soc Psych. 2008 July; 95(1):50-65.
Osvaldo PA, Yeap BB, Hankey GJ, Jamrozik K, Flicker L. Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch Gen Psychiatry. 2008 Mar; 65(3):283-289.
Parsons JK, Bergstrom J, Silberstein J, Barrett-Connor E. Prevalence and characteristics of lower urinary tract symptoms in men aged >/= 80 years. Urology. 2008 Jun 11.
Reid RJ et al. Intimate partner violence among men: Prevalence, chronicity, and health effects. Am J Prev Med. 2008 June; 34(6):478-485.
Sand MS, Fisher W, Rosen R, Heiman J, Eardley I. Erectile dysfunction and constructs of masculinity and quality of life in the multinational Men’s Attitudes to Life Events and Sexuality (MALES) study. 2008 Mar; 5(3):583-594.
Rosen RC et al. Beyond the cluster: Methodological and clinical implications in the Boston Area Community Health Survey and EPIC studies. BJU Int. 2008 May; 101(10):1274-1278.
Savic I, Lindström P. PET and MRI show differences in cerebral asymmetry and functional connectivity between homo – and heterosexual subjects. Proc Natl Acad Sci. 2008 June 16.
Smith JA, Braunack-Mayer A, Wittert G, Warin M. “It’s sort of like being a detective”: Understanding how Australian men self-monitor their health prior to seeking help. BMC Health Services Research. 2008 Mar 14; 8:56.
Stark MJ, Clifton VL, Wright IMR. Sex-specific differences in peripheral microvascular blood flow in preterm infants. Pediatric Research. 2008 Apr; 63(4):415-419.
Tartaglia N et al. A new look at XXYY syndrome: Medical and psychological features. Am J Med Genetics Part A. 2008 May; 146A(12):1509-1522.
Sex, Sexuality & Sexual Health
Bellis MA et al. Sexual uses of alcohol and drugs and the associated health risks: A cross sectional study of young people in nine European cities. BMC Public Health. 2008; 8:155.
Ching-Wan Ma R et al. Erectile dysfunction predicts coronary heart disease in Type 2 diabetes. J Am Coll Cardiol. 2008, May 27; 51:2045-2050.
Dai H et al. The evolution of courtship behaviors through the origination of a new gene in Drosophila. PNAS. 2008 May 27; 105)21):7478-7483.
Fowke J, Murff H, Signorello L, et al. Race and Socioeconomic Status are Independently Associated with Benign Prostatic Hyperplasia. Journal of Urology, 2008 Sept 18.
Gazzaruso C, Solerte SB, Pujia A, et al. Erectile Dysfunction as a Predictor of Cardiovascular Events and Death in Diabetic Patients With Angiographically Proven Asymptomatic Coronary Artery Disease: A Potential Protective Role for Statins and 5-Phosphodiesterase Inhibitors. J Am Coll Cardiol 2008 51: 2040-2044.
Janssen E, McBride KR, Yarber W, Hill BJ, Butler SM. Factors that influence sexual arousal in men: A focus group study. Arch Sex Behav. 2008 Apr; 37(2):1573-2800.
Kigozi G et al. The effect of male circumcision on sexual satisfaction and function, results from a randomized trial of male circumcision for human immunodeficiency virus prevention, Rakai, Uganda. BJU Int. 2008 Jan; 101(1):65-70.
Långström N, Rahman Q, Carlström E, Lichtenstein P. Genetic and environmental effects on same-sex sexual behavior: A population study of twins in Sweden. Arch Sex Behav. 2008 June 7.
Ma R, So W, Yang X, et al. Erectile Dysfunction Predicts Coronary Heart Disease in Type 2 Diabetes. J Am Coll Cardiol 2008 51: 2045-2050.
Manlove J, Terry-Humen E, Ikramullah E, et al. Sexual and Reproductive Health Behaviors Among Teens and Young Adult Men: a Descriptive Portrait. Child Trends. 2008 Oct.
Munger MA et al. Safety of prescribing PDE-5 inhibitors via e-medicine vs traditional medicine.Mayo Clin Proc. 2008 Aug; 83(8):890-896.
Namiki S et al. Sexual function reported by Japanese and American men. J Urol. 2008 Jan; 179(1):245-9.
Van den Bergh B, Dewitte S, Warlop L. Bikinis instigate generalized impatience in intertemporal choice. J Consumer Research. 2008 June; 35(1):85-97.
Men and STDs/STIs & HIV/AIDS
Celum C et al. Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: A randomized, double-blind, placebo-controlled trial. Lancet. 2008 June; 371(9630):2109-2119.
Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for Human Papillomavirus-related and –unrelated oral squamous cell carcinomas in the United States. J Clinical Oncology. 2008 Feb 1; 26(4):612-619.
Darbes LA, Crepaz NB, Lyles CB, Kennedy GC, Rutherford GC. The efficacy of behavioral interventions in reducing HIV risk behaviors and incident sexually transmitted diseases in heterosexual African Americans. AIDS. 2008 June 19; 22(10):1177-1194.
Gray RH, Wawer MJ, Serwadda D, et al. The Role of Male Circumcision in the Prevention of Human Papillomavirus and HIV infectionJournal of Infectious Diseases 2009; 199: 1-3.
Horvath KJ, Rosser BR, Remafedi G. Sexual risk taking among young internet-using men who have sex with men. Am J Public Health. 2008 Apr 29.
Kahn JG, Marseille E, Auvert B. Cost- Effectiveness of Male Circumcision for HIV Prevention in a South African Setting. PLoS Medicine Vol. 3, No. 12, e517 doi:10.1371/journal.pmed.0030.
Kigozi G et al. The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda. PLoS. 2008 June; 5(6):e116.
Liss M, Osann K, Ornstein D. Positive surgical margins during robotic radical prostatectomy: A contemporary analysis of risk factors. BJU Int. 2008 Apr 24.
Millett GA , Flores SA, Marks G, et al. Circumcision Status and Risk of HIV and Sexually Transmitted Infections Among Men Who Have Sex with Men: a Meta-analysis. JAMA. 2008 Oct 8;300(14):1674-84.
Nyitray A et al. Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men. J Infect Dis. 2008 Jun 15; 197(12):1676-1684.
Pask AJ, McInnes KJ, Webb DR, Short RV. Topical oestrogen keratinizes the human foreskin and may help prevent HIV infection. PLoS One. 2008 June 4; 3(6):e2308.
Swanson GP, Goldman B, Tangen CM, et al. The Prognostic Impact of Seminal Vesicle Involvement Found at Prostatectomy and the Effects of Adjuvant Radiation: Data From Southwest Oncology Group 8794. The Journal of Urology. 2008 Oct 17.
Walz J, Haese A, Scattoni V, et al. Percent Free Prostate-Specific Antigen (PSA) is an Accurate Predictor of Prostate Cancer Risk in Men with Serum PSA 2.5 ng/mL and Lower . Cancer. 2008 Oct 13.
Warner L, Ghanem KG, Newman DR, et al Male Circumcision and Risk of HIV Infection Among Heterosexual African American Men Attending Baltimore Sexually Transmitted Disease ClinicsJournal of Infectious Diseases 2009; 199: 59-65.
Wilson DP, Coplan PM, Wainberg MA, Blower SM. The paradoxical effects of using antiretroviral-based xmicrobicides to control HIV epidemics. Proc Natl Acad Sci USA. 2008 Jul 7.
